{"id":"W3200389877","doi":"10.1055/a-1653-4699","title":"Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial","year":2021,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Bayer Vital; Novartis Pharma; LEO Pharma; Servier; ZonMw; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Boston Scientific Corporation; Acceleron; Ministerio de Ciencia e Innovación; Novo Nordisk; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; United Therapeutics Corporation; Bayer; Bristol-Myers Squibb; AstraZeneca; Pfizer; Deutsche Forschungsgemeinschaft","keywords":"Medicine; Thrombolysis; Decompensation; Pulmonary embolism; Cardiology; Hemodynamics; Myocardial infarction; Internal medicine; Pulmonary hypertension; Anesthesia","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0116674,0.002038902,0.003625013,0.0005139232,0.000713283,0.002013785,0.001279373,0.003154945,0.005670438],"category_scores_gemma":[0.008177164,0.0007174996,0.001830925,0.0005921521,0.001465308,0.00112535,0.0007337906,0.003959879,0.0022894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000703729,"about_ca_system_score_gemma":0.001805013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002871252,"about_ca_topic_score_gemma":0.0007292,"domain_scores_codex":[0.9939401,0.004351777,0.0003273722,0.0005028118,0.0005502719,0.0003277036],"domain_scores_gemma":[0.9984946,0.000448207,0.0003399729,0.0001537252,0.0001935385,0.0003699791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.8400052,0.0123007,0.006066201,0.01150664,0.004646932,0.0004930719,0.0003532812,0.002715201,0.005169976,0.01524098,0.01873546,0.08276629],"study_design_scores_gemma":[0.9232212,0.0341764,0.004065864,0.001298358,0.002289554,0.0001723801,0.00005271669,0.002331531,0.0006711885,0.006647562,0.02499002,0.00008320697],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.3379893,0.08092767,0.02692336,0.02709598,0.01241655,0.4537202,0.01042653,0.0005407131,0.04995958],"genre_scores_gemma":[0.5386409,0.01866272,0.03344171,0.01919065,0.004838357,0.3680368,0.005785309,0.0001233237,0.01128028],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.0116674,"threshold_uncertainty_score":0.06170386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04047820421835464,"score_gpt":0.3078143625059836,"score_spread":0.267336158287629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}